Xeris Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell XERS and other ETFs, options, and stocks.About XERS
Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. The company has three commercial products: Gvoke, Keveyis, and Recorlev.
CEOJohn Patrick Shannon
CEOJohn Patrick Shannon
Employees394
Employees394
HeadquartersChicago, Illinois
HeadquartersChicago, Illinois
Founded2005
Founded2005
Employees394
Employees394
XERS Key Statistics
Market cap1.22B
Market cap1.22B
Price-Earnings ratio-67.31
Price-Earnings ratio-67.31
Dividend yield—
Dividend yield—
Average volume2.36M
Average volume2.36M
High today$7.37
High today$7.37
Low today$6.96
Low today$6.96
Open price$7.02
Open price$7.02
Volume4.10M
Volume4.10M
52 Week high$10.08
52 Week high$10.08
52 Week low$3.14
52 Week low$3.14
Stock Snapshot
As of today, Xeris Biopharma(XERS) shares are valued at $7.35. The company's market cap stands at 1.22B, with a P/E ratio of -67.31.
On 2026-01-07, Xeris Biopharma(XERS) stock traded between a low of $6.96 and a high of $7.37. Shares are currently priced at $7.35, which is +5.5% above the low and -0.3% below the high.
Xeris Biopharma(XERS) shares are trading with a volume of 4.1M, against a daily average of 2.36M.
In the last year, Xeris Biopharma(XERS) shares hit a 52-week high of $10.08 and a 52-week low of $3.14.
In the last year, Xeris Biopharma(XERS) shares hit a 52-week high of $10.08 and a 52-week low of $3.14.
Analyst ratings
86%
of 7 ratingsBuy
85.7%
Hold
14.3%
Sell
0%
People also own
Based on the portfolios of people who own XERS. This list is generated using Robinhood data, and it’s not a recommendation.